Nanotechnology makes use of biotechnology

Nanotechnology applications are pushing the boundaries of a number of sectors including electronics. New research in the field of microelectronics facilitates the manufacture of nanodevices at the molecular level based on the use of genetic material.

The EC-funded MINT project focused on the level of interconnections that can be achieved in the new generation of nanodevices. The aim was to achieve at least the same level of interconnections as those in microelectronic systems. Project partners investigated the potential role of ribonucleic acid (RNA) as part of the manufacturing process of original templates.

RNA folds into specific tertiary structures giving researchers the opportunity to exploit this property in order to form new templates for the design of novel nanodevices. Within the framework of MINT, the University of Liverpool designed and characterised a series of self-assembling RNA molecules for the purposes of nanofabrication.

These RNA structures combine either in twos or in fours to form one-dimensional fibres in the presence of magnesium ions. These structures have been designed to facilitate specific and non-specific attachment of RNA molecules to gold nanoparticles, electrodes or surfaces. The resulting RNA-gold fibres have been used successfully as templates for electrochemical deposition of metal on gold surfaces. The aim is to form nanointerconnections between the varied components.

The University is seeking further support to continue this line of research. The applications of this project could have a profound effect on the field of nanotechnology and in particular in the area of nanoelectronics.

Contact Details
BATES, Andy (Dr)
University of Liverpool
Lecturer in Molecular Biology
School of Biological Sciences
L69 7ZB
Liverpool
UNITED KINGDOM
Tel: +44-1517-954563
Fax: +44-1517-954410
URL: http://www.liv.ac.uk/bio/

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...